跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 120 mg - HSA Drug Approval Details
Approvals
/
HSA
/
Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 120 mg
Approved
STANDARD
Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 120 mg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
7fcde43522eb28e8
Company
Unknown
Type
Standard
Approval Details
Approval Id
7fcde43522eb28e8
Drug Name
Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 120 mg
Active Ingredients
Lanreotide Acetate 149.4mg eqv lanreotide
120 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
7fcde43522eb28e8
Type
Standard
Back to HSA Approvals
